Main logo
?
tutorial arrow
×
Create your own tool library
Bookmark tools and put favorites into folders to find them easily.

Arpeggio

Harmonic compression of ChIP-seq data reveals protein-chromatin interaction signatures.

User report

tutorial arrow
×
Vote up tools and offer feedback
Give value to tools and make your expertise visible
Give your feedback on this tool
Sign up for free to join and share with the community

0 user reviews

0 user reviews

No review has been posted.

Arpeggio forum

tutorial arrow
×
Communicate with other users
Participate in the forum to get support for using tools. Ask questions about technical specifications.
Take part in the discussion
Sign up for free to ask question and share your advices

No open topic.

Arpeggio classification

Arpeggio specifications

Software type:
Package/Module
Restrictions to use:
None
Computer skills:
Advanced
Maintained:
Yes
Interface:
Command line interface
Operating system:
Unix/Linux, Mac OS
Stability:
Stable

Arpeggio distribution

versioning

tutorial arrow
×
Upload and version your source code
Get a DOI for each update to improve tool traceability. Archive your releases so the community can easily visualize progress on your work.
Facilitate your tool traceability
Sign up for free to upload your code and get a DOI

No versioning.

Arpeggio support

Documentation

Credits

tutorial arrow
×
Promote your skills
Define all the tasks you managed and assign your profile the appropriate badges. Become an active member.
Promote your work
Sign up for free to badge your contributorship

Publications

Institution(s)

Department of Pathology, Yale University School of Medicine, CT, USA, Department of Exact Sciences, Afeka - Tel-Aviv Academic College of Engineering, Tel-Aviv, Israel, Department Of Liver Transplant, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA; NYU Center for Health Informatics and Bioinformatics, New York University Langone Medical Center, NY, USA

Link to literature

By using OMICtools you acknowledge that you have read and accepted the terms of the end user license agreement.